Professor Ben Grey : Urology

Fee assured
Awaiting verification
Not in Open Referral network

Overview

Specialises in

Benign Prostate disorders

General urology

Urinary tract stones

Offers

Face-to-face consultations
Video and telephone consultations

About us

Ben Grey is a Consultant Urological Surgeon working privately as part of Manchester Urology. His NHS practice is at Manchester University Hospitals NHS Foundation Trust (MFT), working at Manchester Royal Infirmary and Trafford General Hospitals. He is also Honorary Professor at the University of Salford and Honorary Senior Lecturer at the University of Manchester. Ben is proud to have been awarded the prestigious British Association of Urological Surgeons (BAUS) John Anderson Award in 2015 which recognises an individual who has contributed to urology in an outstanding or inspirational way.
Ben practices all components of general urology but he has subspecialty interests in urinary tract stone management (kidney stones, ureteric stones and bladder stones). He is always keen to learn new techniques that can benefit his patients and has performed ‘UK-first’ procedures, on a couple of occasions. As part of Manchester Urology, he offers the full range of therapeutic options for stone disease privately including minimally invasive endourology techniques including ureteroscopy, percutaneous nephrolithotomy (PCNL) and shockwave lithotripsy as well as strategies to reduce the risk of further stone formation. He leads the complex stone service and stone multidisciplinary team (MDT) at MRI/MFT and sees patients from across NW England.
He graduated from the University of Manchester and undertook higher surgical training in Manchester and the North West. He has gained further specialist experience at the Cleveland Clinic in the USA and at stone centres in Amsterdam and Turin. An active researcher, with over 30 publications and book chapters to date, he received his research doctorate (MD) from the University of Manchester after an intensive study of prostate stem cell biology at the Christie Hospital.
He is also a qualified educator (PGCert Distinction) and has recently completed an appointment as Training Programme Director for Urology in Manchester with overall responsibility for the quality of trainee urologists’ education in the region. Ben is an invited faculty member on numerous UK instructional courses and has lectured internationally on the management of stone disease. He has been appointed as a global key opinion leader for two large companies providing endourological equipment.
Ben recognises the importance of audit and submits his data to the various kidney stone-related BAUS audits (https://www.baus.org.uk/patients/surgical_outcomes/pcnl/surgeon.aspx?id=1421). His current research interests focus on service improvement (patient safety/satisfaction and efficiency), with the ultimate aim of maximising patients' experience.
Ben enjoys spending time with his wife watching their children grow up. His playing days are now over but he enjoys watching both rugby and football games and exercises playing squash and running.

Areas of interest

Urinary tract stone disease; Endourology; kidney stones; ureteric stones; bladder stones; Lower Urinary Tract Symptoms (LUTS); benign prostate diseases; loin pain; incontinence; haematuria (blood in the urine); urinary tract infection (UTI); raised PSA; diseases of the penis and scrotum; scrotal lumps; foreskin problems; urological cancer

Medical secretaries

Nicky Fuller (Secretary)
Manchester Urology LLP Manor Lodge Mill Lane CHEADLE SK8 2NT
0161 495 7791
0161 428 7657
n.fuller@manchesterurology.org.uk

Anaesthetists worked with

Dr Manoj Sanwal Fee Assured
Dr Kamran Abbas Not Fee Assured

Dr Nicholas Peter Arthur Greenwood Fee Assured
Dr Janis Shaw Fee Assured

About us

External resources

Awards received

MFT Excellence Awards - Runner-Up Team of the Year, 2019
BAUS John Anderson Award, 2015
HSJ Patient Safety Award Finalist, 2015
CMFT Patient Safety Award Winner, 2015
Best Paper in Conference at BAUS Annual Meeting,
Liverpool, 2011.
Best Presentation in Prostate Cancer Tumour Cell Biology at EAU Annual Meeting,
Stockholm, 2009.
Best Presentation in Testis Cancer at EAU Annual Meeting,
Berlin, 2007.

Publications

Last 9 years:
Baston EL, .....Grey BR.
Office-based ureteric stent removal is achievable, improves clinical flexibility and quality of care, whilst also keeping surgeons close to their patients.
Cent European J Urol. 2018;71(2):196-201

Smith PM,......Grey BR.
Isiris: A Novel Method of Removing Foreign Bodies from the Lower Urinary Tract to Avoid Unnecessary Hospitalization and Anesthesia.
J Endourol Case Rep. 2016 Aug 1; 2(1):144-7.

Rukin NJ, Somani BK, Patterson J, Grey BR et al.
Tips and tricks of ureteroscopy: consensus statement. Part II. Advanced ureteroscopy.
Cent European J Urol. 2016;69(1):98-104.

Rezvani S,...Grey BR et al.
Dissolution of extensive urolithiasis: extending the utility of rasburicase can avoid the need for surgical intervention and renal replacement therapy.
J Surg Case Rep 2016; 2: 1-3.

Rukin NJ, Somani BK, Patterson J, Grey BR et al.
Tips and tricks of ureteroscopy: consensus statement Part I. Basic ureteroscopy.
Central European Journal of Urology 2015; 68(4): 439-446.

Zelhof B,....Grey BR.
Nephrectomy for benign disease in the UK: results from the British Association of Urological Surgeons nephrectomy database.
BJU International 2016; 117(1): 138-44.

Grey BR, et al.
UK practice regarding reversal of vasectomy 2001 â€“ 2010: relevance to best contemporary patient management.
BJU International 2012; 110(7): 1040-7.

Grey BR, et al.
UK urology trainees' exposure to dedicated infertility training: how good is that training?
British Journal of Medical and Surgical Urology 2012; 5: 34-38.

Ramani VA, Maddineni SB, Grey BR, Clarke NW.
Differential Complication Rates Following Radical Cystectomy in the Irradiated and Nonirradiated Pelvis.
European Urology 2010; 57 (6): 1058-63.

Oates JE and Grey BR, et al.
Hoechst 33342 side population identification is a conserved and unified mechanism in urological cancers.
Stem Cells and Development 2009: 18 (10): 1515-22.

Grey BR, et al.
The Effect of Intravesical Single-Dose Mitomycin C in Recurrent Superficial Bladder Cancer.
British Journal of Medical and Surgical Urology 2009: 2; 73-79 .

Grey BR, et al.
CD133: a marker of transit amplification rather than stem cell phenotype in the prostate?
BJU International 2009: 103 (7); 856-858.

Grey BR, et al.
Male adnexal tumour of wolffian origin: The first report of metastatic disease.
Scand J Urol Nephrol 2009; 43 (3): 253-6.

Courses offered to GPs

By request, all aspects of Urology can be covered.

About our work

Our outcomes

Our qualifications & training

Accreditations

Bachelor of Medicine and Surgery (MBChB) University of Manchester 2001
Membership of the Royal College of Surgeons of England (MRCS Eng) Royal College of Surgeons of England 2004
Doctorate of Medicine (MD) University of Manchester 2009
Fellowship of the Royal College of Surgeons (FRCSUrol) Royal College of Surgeons of England 2012
Postgraduate Certificate in Workplace-Based Medical Education (PGCert) Edgehill University 2013

GMC registration

Reference number 6028677

Affiliations / memberships

Honorary Professor, University of Salford
North Western Deanery Tutor in Clinical Education
Honorary Senior Lecturer at the University of Manchester
Royal College of Surgeons of England (RCSEng)
British Association of Urological Surgeons (BAUS)
BAUS Section of Endourology Member
BAUS Section of Andrology Member
BAUS Section of Oncology Member
General Medical Council

Our private practice

Practice hours

Practice
Day
Hours
Appt Bookings

BMI The Alexandra Hospital, SK8 2PX
Wednesday
11:00 - 14:30
0161 495 7791

Spire Manchester Hospital, M20 2AF
Monday
18:00 - 20:30
0161 495 7791

Post treatment communication

Following treatment of a Bupa member, we will communicate with GPs in line with Department of Health, GMC and appropriate professional bodies guidelines.

Finder

Note: